{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:01:55Z","timestamp":1795147315916,"version":"4.10.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["GT15758"],"award-info":[{"award-number":["GT15758"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM136542"],"award-info":[{"award-number":["T32GM136542"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K99GM155613"],"award-info":[{"award-number":["K99GM155613"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["1U54CA263001-01A1"],"award-info":[{"award-number":["1U54CA263001-01A1"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Somatic mutations rewire the ubiquitin\u2013proteasome system (UPS) to support tumor growth, but the proteome-wide consequences of cancer-driver alterations on UPS composition remain incompletely understood. Using harmonized proteogenomic data from up to 11 CPTAC cohorts, we performed an integrated pan-cancer analysis of UPS protein dysregulation, prognostic associations, and mutation-driven remodeling. We show that mRNA poorly predicts UPS protein abundance, that a defined set of E3 ligases is recurrently dysregulated across cancers, and that somatic mutations (most strikingly\n                    <jats:italic>TP53<\/jats:italic>\n                    loss) produce coherent UPS protein-quantitative trait locus (pQTL) signatures. Two case studies (UBR5 and TRIM28) illustrate orthogonal modes of UPS rewiring: a mutation-driven axis in which\n                    <jats:italic>TP53<\/jats:italic>\n                    -mutant tumors elevate UBR5 to support replication stress tolerance, and a lineage-driven axis in which TRIM28 engages tissue-restricted regulatory networks with opposing prognostic effects in glioblastoma versus head and neck cancer. Each axis exposes context-specific therapeutic vulnerabilities, including sensitivity to DNA damage response inhibitors (UBR5-high) and lineage-specific drug responses (TRIM28-high). Together, these analyses define a mechanistic framework for how cancer-driver mutations reshape proteostasis through the UPS and nominate mutation- and lineage-defined dependencies for precision degrader therapy. The harmonized pan-tissue atlas and the UbiDash interactive resource that underpin parts of this analysis are reported in our companion paper [1].\n                  <\/jats:p>","DOI":"10.1038\/s41418-026-01787-6","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T10:22:55Z","timestamp":1784456575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pan-cancer proteogenomic interrogation of the ubiquitin-proteasome system"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-382X","authenticated-orcid":false,"given":"Tania J.","family":"Gonz\u00e1lez-Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sastourn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Triola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6884-3886","authenticated-orcid":false,"given":"Sharon","family":"Kaisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Feny\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Rona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-7917","authenticated-orcid":false,"given":"Yadira M.","family":"Soto-Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-585X","authenticated-orcid":false,"given":"Benjamin G.","family":"Neel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly V.","family":"Ruggles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3210-2442","authenticated-orcid":false,"given":"Michele","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","unstructured":"Gonzalez Robles TJ, Sastourn\u00e9 P, Triola M, Khan M, Bartha \u00c1, et al. UbiDash: A harmonized UPS proteomic atlas for tissue-aware degrader design. Cell Death Differ. 2026. https:\/\/doi.org\/10.1038\/s41418-026-01791-w","DOI":"10.1038\/s41418-026-01791-w"},{"key":"1787_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1787_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1787_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"1787_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.tibs.2024.06.006","volume":"49","author":"L M\u00fcller","year":"2024","unstructured":"M\u00fcller L, Hoppe T. UPS-dependent strategies of protein quality control degradation. Trends Biochem Sci. 2024;49:859\u201374.","journal-title":"Trends Biochem Sci"},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","volume":"25","author":"JM Tsai","year":"2024","unstructured":"Tsai JM, Nowak RP, Ebert BL, Fischer ES. Targeted protein degradation: from mechanisms to clinic. Nat Rev Mol Cell Biol. 2024;25:740\u201357.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1787_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther. 2022;7:113.","journal-title":"Signal Transduct Target Ther"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","volume":"9","author":"G Zhong","year":"2024","unstructured":"Zhong G, Chang X, Xie W, Zhou X. Targeted protein degradation: advances in drug discovery and clinical practice. Signal Transduct Target Ther. 2024;9:308.","journal-title":"Signal Transduct Target Ther"},{"key":"1787_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ccell.2025.05.012","volume":"43","author":"Y Du","year":"2025","unstructured":"Du Y, Wu J. A unified pan-cancer proteome atlas. Cancer Cell. 2025;43:1201\u20131203.","journal-title":"Cancer Cell"},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.chembiol.2021.04.008","volume":"28","author":"S Duan","year":"2021","unstructured":"Duan S, Pagano M. Ubiquitin ligases in cancer: functions and clinical potentials. Cell Chem Biol. 2021;28:918\u201333.","journal-title":"Cell Chem Biol"},{"key":"1787_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nrd2056","volume":"5","author":"G Nalepa","year":"2006","unstructured":"Nalepa G, Rolfe M, Harper JW. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov. 2006;5:596\u2013613.","journal-title":"Nat Rev Drug Discov"},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.molcel.2021.01.020","volume":"81","author":"C Tokheim","year":"2021","unstructured":"Tokheim C, Wang X, Timms RT, Zhang B, Mena EL, Wang B, et al. Systematic characterization of mutations altering protein degradation in human cancers. Mol Cell. 2021;81:1292\u2013308.e11.","journal-title":"Mol Cell"},{"key":"1787_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s43018-019-0001-2","volume":"1","author":"Francisco Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez Francisco, Mui\u00f1os F, L\u00f3pez-Arribillaga E, Lopez-Bigas N, Gonzalez-Perez A. Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer. Nat Cancer. 2020;1:122\u201335.","journal-title":"Nat Cancer"},{"key":"1787_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrc.2017.105","volume":"18","author":"D Senft","year":"2018","unstructured":"Senft D, Qi J, Ronai ZA. Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat Rev Cancer. 2018;18:69\u201388.","journal-title":"Nat Rev Cancer"},{"key":"1787_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.celrep.2018.03.047","volume":"23","author":"Z Ge","year":"2018","unstructured":"Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, et al. Integrated genomic analysis of the ubiquitin pathway across cancer types. Cell Rep. 2018;23:213\u201326.e3.","journal-title":"Cell Rep"},{"key":"1787_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","volume":"19","author":"M Rape","year":"2018","unstructured":"Rape M. Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol. 2018;19:59\u201370.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1787_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0092-8674(03)01074-2","volume":"116","author":"CM Pickart","year":"2004","unstructured":"Pickart CM. Back to the future with ubiquitin. Cell. 2004;116:181\u201390.","journal-title":"Cell"},{"key":"1787_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92177-4","volume":"15","author":"D Sun","year":"2025","unstructured":"Sun D, Duan X, Li N, Qiao O, Hou Y, Ma Z, et al. Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma. Sci Rep. 2025;15:11787.","journal-title":"Sci Rep"},{"key":"1787_CR19","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.cell.2026.01.029","volume":"189","author":"NK Chua","year":"2026","unstructured":"Chua NK, Gonz\u00e1lez-Robles TJ, Reddington CJ, Dudley-Fraser J, Birkinshaw RW, Han J, et al. The E3-ome gene-centric compendium reveals the human E3 ligase landscape. Cell. 2026;189:2167\u201388.e27.","journal-title":"Cell"},{"key":"1787_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41587-024-02164-9","volume":"42","author":"K Garber","year":"2024","unstructured":"Garber K. The glue degraders. Nat Biotechnol. 2024;42:546\u201350.","journal-title":"Nat Biotechnol"},{"key":"1787_CR21","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1039\/D2CS00197G","volume":"51","author":"A Domostegui","year":"2022","unstructured":"Domostegui A, Nieto-Barrado L, Perez-Lopez C, Mayor-Ruiz C. Chasing molecular glue degraders: screening approaches. Chem Soc Rev. 2022;51:5498\u2013517.","journal-title":"Chem Soc Rev"},{"key":"1787_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.chembiol.2021.04.009","volume":"28","author":"Z Kozicka","year":"2021","unstructured":"Kozicka Z, Thom\u00e4 NH. Haven\u2019t got a glue: protein surface variation for the design of molecular glue degraders. Cell Chem Biol. 2021;28:1032\u201347.","journal-title":"Cell Chem Biol"},{"key":"1787_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/acs.biochem.1c00464","volume":"62","author":"BP Belcher","year":"2023","unstructured":"Belcher BP, Ward CC, Nomura DK. Ligandability of E3 ligases for targeted protein degradation applications. Biochemistry. 2023;62:588\u2013600.","journal-title":"Biochemistry"},{"key":"1787_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1158\/2159-8290.CD-25-1187","volume":"16","author":"N Roy","year":"2026","unstructured":"Roy N, Wyseure T, Lo I-C, Lu J, Eissler CL, Bernard SM, et al. A covalent allosteric molecular glue suppresses NRF2-dependent cancer growth. Cancer Discov. 2026;16:953\u201375.","journal-title":"Cancer Discov"},{"key":"1787_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022;21:181\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"1787_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1021\/acs.biochem.2c00245","volume":"62","author":"JM Sasso","year":"2023","unstructured":"Sasso JM, Tenchov R, Wang D, Johnson LS, Wang X, Zhou QA. Molecular glues: the adhesive connecting targeted protein degradation to the clinic. Biochemistry. 2023;62:601\u201323.","journal-title":"Biochemistry"},{"key":"1787_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","volume":"180","author":"Y Dou","year":"2020","unstructured":"Dou Y, Kawaler EA, Cui Zhou D, Gritsenko MA, Huang C, Blumenberg L, et al. Proteogenomic characterization of endometrial carcinoma. Cell. 2020;180:729\u201348.e26.","journal-title":"Cell"},{"key":"1787_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100004","volume":"1","author":"JE McDermott","year":"2020","unstructured":"McDermott JE, Arshad OA, Petyuk VA, Fu Y, Gritsenko MA, Clauss TR, et al. Proteogenomic characterization of ovarian HGSC implicates mitotic kinases, replication stress in observed chromosomal instability. Cell Rep Med. 2020;1:100004.","journal-title":"Cell Rep Med"},{"key":"1787_CR29","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","volume":"183","author":"K Krug","year":"2020","unstructured":"Krug K, Jaehnig EJ, Satpathy S, Blumenberg L, Karpova A, Anurag M, et al. Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell. 2020;183:1436\u201356.e31.","journal-title":"Cell"},{"key":"1787_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01548-2","volume":"21","author":"J Fan","year":"2022","unstructured":"Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, et al. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer. 2022;21:87.","journal-title":"Mol Cancer"},{"key":"1787_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0857-2","volume":"17","author":"C-H Yeh","year":"2018","unstructured":"Yeh C-H, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer. 2018;17:115.","journal-title":"Mol Cancer"},{"key":"1787_CR32","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41556-020-0560-6","volume":"22","author":"L Moro","year":"2020","unstructured":"Moro L, Simoneschi D, Kurz E, Arbini AA, Jang S, Guaragnella N, et al. Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis. Nat Cell Biol. 2020;22:1130\u201342.","journal-title":"Nat Cell Biol"},{"key":"1787_CR33","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nprot.2016.057","volume":"11","author":"P Giansanti","year":"2016","unstructured":"Giansanti P, Tsiatsiani L, Low TY, Heck AJR. Six alternative proteases for mass spectrometry\u2013based proteomics beyond trypsin. Nat Protoc. 2016;11:993\u20131006.","journal-title":"Nat Protoc"},{"key":"1787_CR34","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1093\/molbev\/msab095","volume":"38","author":"M Cagiada","year":"2021","unstructured":"Cagiada M, Johansson KE, Valanciute A, Nielsen SV, Hartmann-Petersen R, Yang JJ, et al. Understanding the origins of loss of protein function by analyzing the effects of thousands of variants on activity and abundance. Mol Biol Evol. 2021;38:3235\u201346.","journal-title":"Mol Biol Evol"},{"key":"1787_CR35","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/nm.4407","volume":"23","author":"R Romero","year":"2017","unstructured":"Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med. 2017;23:1362\u20138.","journal-title":"Nat Med"},{"key":"1787_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"EA Collisson","year":"2014","unstructured":"Collisson EA, Campbell JD, Brooks AN, Berger AH, Lee W, Chmielecki J, et al. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543\u201350.","journal-title":"Nature"},{"key":"1787_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ccell.2016.06.022","volume":"30","author":"AH Berger","year":"2016","unstructured":"Berger AH, Brooks AN, Wu X, Shrestha Y, Chouinard C, Piccioni F, et al. High-throughput phenotyping of lung cancer somatic mutations. Cancer Cell. 2016;30:214\u201328.","journal-title":"Cancer Cell"},{"key":"1787_CR38","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","volume":"184","author":"S Satpathy","year":"2021","unstructured":"Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell. 2021;184:4348\u201371.e40.","journal-title":"Cell"},{"key":"1787_CR39","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.18632\/aging.202414","volume":"13","author":"J Han","year":"2021","unstructured":"Han J, Zhao Z, Zhang N, Yang Y, Ma L, Feng L, et al. Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism. Aging. 2021;13:5034\u201354.","journal-title":"Aging"},{"key":"1787_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41589-023-01414-2","volume":"20","author":"LA Hehl","year":"2024","unstructured":"Hehl LA, Horn-Ghetko D, Prabu JR, Vollrath R, Vu DT, P\u00e9rez Berrocal DA, et al. Structural snapshots along K48-linked ubiquitin chain formation by the HECT E3 UBR5. Nat Chem Biol. 2024;20:190\u2013200.","journal-title":"Nat Chem Biol"},{"key":"1787_CR41","doi-asserted-by":"publisher","first-page":"11243","DOI":"10.1073\/pnas.1610735113","volume":"113","author":"A Sanchez","year":"2016","unstructured":"Sanchez A, De Vivo A, Uprety N, Kim J, Stevens SM, Kee Y. BMI1\u2013UBR5 axis regulates transcriptional repression at damaged chromatin. Proc Natl Acad Sci. 2016;113:11243\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"1787_CR42","doi-asserted-by":"publisher","first-page":"11268","DOI":"10.1093\/nar\/gkz824","volume":"47","author":"L Cipolla","year":"2019","unstructured":"Cipolla L, Bertoletti F, Maffia A, Liang C-C, Lehmann AR, Cohn MA, et al. UBR5 interacts with the replication fork and protects DNA replication from DNA polymerase \u03b7 toxicity. Nucleic Acids Res. 2019;47:11268\u201383.","journal-title":"Nucleic Acids Res"},{"key":"1787_CR43","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molcel.2023.06.028","volume":"83","author":"JM Tsai","year":"2023","unstructured":"Tsai JM, Aguirre JD, Li Y-D, Brown J, Focht V, Kater L, et al. UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability. Mol Cell. 2023;83:2753\u201367.e10.","journal-title":"Mol Cell"},{"key":"1787_CR44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/ijc.34769","volume":"154","author":"Z Yu","year":"2024","unstructured":"Yu Z, Dong X, Song M, Xu A, He Q, Li H, et al. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis. Int J Cancer. 2024;154:723\u201337.","journal-title":"Int J Cancer"},{"key":"1787_CR45","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1080\/15548627.2021.1897961","volume":"17","author":"N Suzuki","year":"2021","unstructured":"Suzuki N, Johmura Y, Wang T-W, Migita T, Wu W, Noguchi R, et al. TP53\/p53-FBXO22-TFEB controls basal autophagy to govern hormesis. Autophagy. 2021;17:3776\u201393.","journal-title":"Autophagy"},{"key":"1787_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41392-023-01362-2","volume":"8","author":"J Hu","year":"2023","unstructured":"Hu J, Tan P, Ishihara M, Bayley NA, Schokrpur S, Reynoso JG, et al. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduct Target Ther. 2023;8:155.","journal-title":"Signal Transduct Target Ther"},{"key":"1787_CR47","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-024-08136-y","volume":"637","author":"A Bhardwaj","year":"2025","unstructured":"Bhardwaj A, Panepinto MC, Ueberheide B, Neel BG. A mechanism for hypoxia-induced inflammatory cell death in cancer. Nature. 2025;637:470\u20137.","journal-title":"Nature"},{"key":"1787_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"1787_CR49","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"1787_CR50","doi-asserted-by":"publisher","unstructured":"Shimada K, Muhlich JL, Mitchison TJ A tool for browsing the Cancer Dependency Map reveals functional connections between genes and helps predict the efficacy and selectivity of candidate cancer drugs. 2019. https:\/\/doi.org\/10.1101\/2019.12.13.874776.","DOI":"10.1101\/2019.12.13.874776"},{"key":"1787_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","volume":"25","author":"R Arafeh","year":"2025","unstructured":"Arafeh R, Shibue T, Dempster JM, Hahn WC, Vazquez F. The present and future of the Cancer Dependency Map. Nat Rev Cancer. 2025;25:59\u201373.","journal-title":"Nat Rev Cancer"},{"key":"1787_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer. 2020;1:235\u201348.","journal-title":"Nat Cancer"},{"key":"1787_CR53","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1093\/nar\/gkad732","volume":"51","author":"A de Vivo","year":"2023","unstructured":"de Vivo A, Song H, Lee Y, Tirado-Class N, Sanchez A, Westerheide S, et al. OTUD5 limits replication fork instability by organizing chromatin remodelers. Nucleic Acids Res. 2023;51:10467\u201383.","journal-title":"Nucleic Acids Res"},{"key":"1787_CR54","doi-asserted-by":"crossref","unstructured":"Zhang S, Lanz MC, Konschnik J, Skotheim JM Chromatin association promotes UBR5-mediated degradation of Rb. 2026; 2026.04.16.719064.","DOI":"10.64898\/2026.04.16.719064"},{"key":"1787_CR55","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s41418-022-01036-6","volume":"29","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Huang X, Zhu D, Wei M, Luo J, Yu S, et al. Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy. Cell Death Differ. 2022;29:2531\u201344.","journal-title":"Cell Death Differ"},{"key":"1787_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102202","volume":"6","author":"A DeCarlo","year":"2025","unstructured":"DeCarlo A, MacLeod G, Fernandes Da Silva C, Shen LQ, Povilaikaite J, Deane M, et al. Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastoma. Cell Rep Med. 2025;6:102202.","journal-title":"Cell Rep Med"},{"key":"1787_CR57","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"PS Hammerman","year":"2012","unstructured":"Hammerman PS, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519\u201325.","journal-title":"Nature"},{"key":"1787_CR58","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"MS Lawrence","year":"2015","unstructured":"Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576\u201382.","journal-title":"Nature"},{"key":"1787_CR59","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1073\/pnas.081474898","volume":"98","author":"M Gstaiger","year":"2001","unstructured":"Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci. 2001;98:5043\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"1787_CR60","first-page":"2613","volume":"9","author":"M Drobnjak","year":"2003","unstructured":"Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B, et al. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients1. Clin Cancer Res. 2003;9:2613\u20139.","journal-title":"Clin Cancer Res"},{"key":"1787_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04179-5","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Gu L, Wu N, Song J, Yan J, Yang S, et al. Overexpression of DTL enhances cell motility and promotes tumor metastasis in cervical adenocarcinoma by inducing RAC1-JNK-FOXO1 axis. Cell Death Dis. 2021;12:929.","journal-title":"Cell Death Dis"},{"key":"1787_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20140-0","volume":"11","author":"M Song","year":"2020","unstructured":"Song M, Yeku OO, Rafiq S, Purdon T, Dong X, Zhu L, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11:6298.","journal-title":"Nat Commun"},{"key":"1787_CR63","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1158\/0008-5472.CAN-16-2409","volume":"77","author":"L Liao","year":"2017","unstructured":"Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, et al. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2017;77:2090\u2013201.","journal-title":"Cancer Res"},{"key":"1787_CR64","doi-asserted-by":"publisher","first-page":"108079","DOI":"10.18632\/oncotarget.22531","volume":"8","author":"Z Xie","year":"2017","unstructured":"Xie Z, Liang H, Wang J, Xu X, Zhu Y, Guo A, et al. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer. Oncotarget. 2017;8:108079\u201392.","journal-title":"Oncotarget"},{"key":"1787_CR65","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/sj.bjc.6604281","volume":"98","author":"PM O\u2019Brien","year":"2008","unstructured":"O\u2019Brien PM, Davies MJ, Scurry JP, Smith AN, Barton CA, Henderson MJ, et al. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br J Cancer. 2008;98:1085\u201393.","journal-title":"Br J Cancer"},{"key":"1787_CR66","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1074\/mcp.TIR119.001646","volume":"19","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Orre LM, Zhou Tran Y, Mermelekas G, Johansson HJ, Malyutina A, et al. DEqMS: a method for accurate variance estimation in differential protein expression analysis. Mol Cell Proteom MCP. 2020;19:1047\u201357.","journal-title":"Mol Cell Proteom MCP"},{"key":"1787_CR67","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1787_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"1787_CR69","unstructured":"Sergushichev AA An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. 2016; 060012."},{"key":"1787_CR70","unstructured":"Dolgalev I msigdbr: MSigDB Gene Sets for Multiple Organisms in a Tidy Data Format. 2025.https:\/\/cran.r-project.org\/web\/packages\/msigdbr\/index.html (accessed 17 Nov2025)."},{"key":"1787_CR71","unstructured":"Harrell, F Jr., & Dupont, Ch Hmisc Harrell Miscellaneous. R Package Version 4.2-0. - References - Scientific Research Publishing. https:\/\/www.scirp.org\/reference\/referencespapers?referenceid=3118318 (accessed 17 Nov2025) (2019)."}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01787-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01787-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T11:00:49Z","timestamp":1784458849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01787-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":71,"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01787-6","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MP is or has been an advisor for SEED Therapeutics, CullGen, Deargen, Kymera Therapeutics, Lumanity, Serinus Biosciences, Sibylla Biotech, Triana Biomedicines, and Umbra Therapeutics. MP also has financial interests in CullGen, Kymera Therapeutics, SEED Therapeutics, Thermo Fisher Scientific, and Triana Biomedicines. BGN serves on the scientific advisory board of Arvinas and receives consulting fees and equity (stock options); is a founder of Lighthorse Therapeutics with founder equity; holds stock options in Recursion Pharma; has a spouse who owns 740 shares of Rev Med; and is a founder of Aethon Therapeutics, receiving consulting fees and founder equity. YMSF is a consultant for Scaffold Therapeutics. The findings presented in this manuscript were not discussed with any person from these companies. The remaining authors declare no other competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors used ChatGPT 5.o to improve writing clarity and syntax of this manuscript. The final version was thoroughly reviewed and approved by all authors.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Ethics"}}]}}